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Abstract 
Objective: The present study aimed to evaluate in vivo the antihyperglycemic, anti 
oxidant,antihyperlipidemic and nephroprotective effects of Stevioside against Alloxan induced diabetic 
nephropathy in rats. Materials and Methods: In this model diabetes was induced using Alloxan (125 mg/
kg, i.p) and the prophylactic treatment was started 48 hours after Alloxan injection for 28 days. The 
protective effect of the treatment with standard (Glibenclamide 0.5mg/kg, p.o) and Stevioside (250 mg/
kg. p.o) were analyzed by estimating the serum levels of glucose, urea, creatinine, albumin, total protein, 
total cholesterol (TCH), triglycerides (TG), high density lipoproteins (HDL) and antioxidants like SOD, 
catalase and lipid peroxidation. Key Findings: This study demonstrates that Stevioside improved 
hyperglycemia and maintained antioxidant status and reduced total cholesterol, TG, urea, creatinine and 
albumin and lipid peroxidation levels when compared to toxic control. The protective effect of Stevioside 
against Alloxan induced diabetic nephropathy in rats was also supported by histopathologic findings.The 
results of the present study are encouraging for its potential use to delay the onset and progression of 
diabetic renal complications. However, the translation of therapeutic efficacy in humans requires further 
studies.  
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Introduction 
Diabetes mellitus is a metabolic disorder 
characterized by chronic hyperglycemia with 
disturbances of carbohydrate, fat and protein 
metabolism due to defects in insulin secretion, insulin 
action, or both. The chronic hyperglycemia of diabetes 
is associated with long-term damage, dysfunction and 
failure of various organs, especially the eyes; kidneys, 
nerves, heart, and blood vessels referred to us 
retinopathy, nephropathy, neuropathy and 
cardiomyopathy respectively (1). 
Diabetic Nephropathy is a progressive kidney 
disease caused by damage to the capillaries in the 
kidney's glomeruli due to longstanding diabetes 
mellitus. Renal disease in diabetes is found to be 
associated with abnormalities of vasodilation and 
generates reactive oxygen species mediated by 
endothelial derived nitric oxide (NO) (2). 
Experimental evidence has supported that 
reactive oxygen species play a role in both pathogenesis 
and numerous pathophysiological mechanisms that 
trigger diabetic complications. The possible 
biochemical mechanisms include activation of the 
polyol pathway, activation of protein kinase C (PKC), 
formation of glycation end products and increased 
oxygen stress (3). 
The pathogenesis of diabetes mellitus are 
managed by insulin and oral administration of 
hypoglycemic drugs such as sulfonylureas and 
biguanides (4).Unfortunately, apart from having a 
number of side effects, none of the oral synthetic 
hypoglycemic agents have been successful in diabetes 
management and controlling long-term micro vascular 
and macro vascular complications (5). 
Prior to the discovery of insulin dietary measures 
and the traditional medicines derived from plants were 
the major forms of treatment for diabetes and its 
complications.  Among the anti-diabetic plants, Stevia 
(Stevia rebaudiana Bertoni) that belongs to the 
Asteraceae family is one of the most efficacious plants. 
The basic building block that gives a sweet taste to the 
leaves of the stevia is glycoside (Stevioside) (6).A 
number of studies have suggested that, beside 
sweetness, stevioside may also offer therapeutic 
benefits, as they have anti-hyperglycemic, anti-
hypertensive, anti-inflammatory and anti-cancer effects 
(7). 
Extract from as Stevia rebaudiana has long been 
used for the treatment of diabetes. It also exhibits a high 
degree of antioxidant activity which has been attributed 
to the scavenging of free radical electrons and 
superoxides. They also do not induce a glycemic 
response when ingested, making them attractive as 
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natural sweeteners to diabetics and others on 
carbohydrate-controlled diets (8). 
The reported mechanism of action for steviol 
glycosides involves the enhanced secretion of insulin 
from β cell of pancreas and insulin sensitivity of 
peripheral tissues, promoting glucose uptake 
(9,10).Stevioside also inhibits glucose production by 
inhibiting glucagon secretion from α cell of pancreas, 
which affects gluconeogenesis and glycogenolysis (11). 
Previous studies reported anti-hyperglycemic 
activity of both aqueous extract of Stevia rebaudiana 
and the isolated Stevioside (10,12,13).But till now there 
is no reported study on the use of Stevioside, the active 
phytoconstituent against diabetes related complications. 
Hence the present study was designed to evaluate the 
effect of Stevioside against alloxan induced diabetic 
nephropathy in rats. 
 
Materials and Methods 
Experimental animals 
Rats of either sex weighing 175-250 g were 
housed in standard polypropylene cages and maintained 
under controlled room temperature (25° ± 5°C) and 
humidity (55 ± 5%) in a well-ventilated animal house 
under 12:12 h light and dark cycle. All the rats were 
provided with commercially available standard pellet 
diet, water ad libitum. Prior to each study, the animals 
were made to fast for 12–14 h but had free access to 
water. The guidelines of committee for the purpose of 
control and supervision of experiments on animals 
(CPSCEA), Govt. of India were followed and prior 
permission was sought from the institutional animal 
ethics committee for conducting the study. 
 
Procurement of Stevioside and its dose selection 
Pure Stevioside was procured from Yucca 
Enterprises, Mumbai, India in the month of June, 
2013.Stevioside solution was suspended using water 
and administered orally to the animals by gastric 
intubation using a force feeding needle. Based on an 
earlier literature review therapeutic dose of Stevioside 
in rats was found to be 250 mg/kg and the same dose 
was selected for the present study (14). 
 
Experimental Model: Alloxan induced diabetic 
nephropathy (15,16) 
Diabetes was induced by intra peritoneal 
injection of a freshly prepared aqueous solution of 5% 
alloxan monohydrate (125mg/kg body weight) in 
normal Saline. After 24h fasting, blood was withdrawn 
from the tail vein for glucose analysis. 48h after alloxan 
administration, rats with fasting glucose ranging from 
210-220 mg/dl showing clear signs of polyuria, 
polyphagia and polydipsia were considered diabetic. 
Animals with fasting blood glucose less than 200 mg/dl 
was not used for experimentation. 
 
Experimental design 
Overnight fasted rats were divided into four 
groups containing 6 animals in each group. Treatment 
with Stevioside was started 48h after alloxan injection 
and continued for 4 weeks. 
 Group I - Normal Control 
 Group II - Toxic Control (Alloxan 125mg/kg, 
i.p.) 
 Group III -  Standard (Glibenclamide 0.5mg/kg 
P.O.) 
 Group IV - Stevioside (250 mg/kg p.o.) 
 
2.5. Biochemical parameters 
Blood glucose was measured with Blood 
glucose kit (Robonik India Pvt Ltd, Mumbai) at 
weekly intervals on day 7, 14, 21 and 28 after daily 
administration of stevioside orally. 24 hours after the 
last treatment blood was collected by retro orbital 
puncture and serum was separated by centrifugation. 
Then after sacrificing the animals kidney samples were 
collected. Kidney samples collected were used for 
histopathological analysis and preparation of Kidney 
tissue homogenate. Both serum and Kidney tissue 
homogenate was subjected for different biochemical 
parameters like Blood urea nitrogen, Creatinine, Total 
protein, Total cholesterol, Triglycerides, HDL-
cholesterol in serum and SOD, catalase and lipid 
peroxidation in Kidney tissue homogenate (17-26). 
 
Preparation of Kidney Tissue Homogenate (27) 
Samples of kidneys (100 mg mL-1 buffer) were 
homogenized using a mortar and pestle in 50 mM 
phosphate buffer (pH 7.0), and then centrifuged at 
10,000 RPM for 15 min; the supernatant thus obtained 
was used for biochemical analysis. 
 
Statistical Analysis 
Results were expressed as mean ±SEM. 
Statistical significance was assessed using One-way 
analysis of variance (ANOVA) followed by Tukey-
Karmer multiple comparison tests by Graphpad Instat 
3.06 software.  P ≤ 0.05 was considered significant. 
 
Results 
Anti-diabetic activity 
Single dose alloxan monohydrate (125 mg/kg) 
significantly (P <0.01) increases the blood glucose as 
shown in Table 1. After the daily oral administration 
with Stevioside (250 mg/kg, p.o.), for 28 days, 
extremely significant (P<0.001) decrease in the blood 
glucose levels was observed in the diabetic rats. 
 
Effect of Stevioside on antioxidant levels in kidney 
tissue homogenate (KTH) 
The effect of Stevioside on antioxidant levels in 
KTH of Alloxan induced diabetic rats was shown in 
Table 2. In this experimental model, toxic control 
revealed an extremely significant (P<0.001) decrease 
of SOD and catalase activity and an extremely 
significant (P<0.001) increase in lipid peroxidation in 
KTH when compared to normal control. The 
prophylactic treated groups like standard and 
stevioside (250mg/kg) demonstrated an extremely 
significant (P<0.001) increase of SOD and catalase 
activity when compared with toxic control while an 
extremely significant (P<0.001) and moderately 
significant (P<0.01) decrease in lipid peroxidation is 
shown by the standard and Stevioside. 
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Effect on Lipoproteins 
In toxic control group, there was an extremely 
significant (P<0.001) increase of serum total cholesterol 
& triglycerides, and an extremely significant (P<0.001) 
decrease of HDL cholesterol when compared to that of 
normal controls. The standard drug as well as Stevioside 
(250 mg/kg) used in the experimental study showed an 
extremely significant decrease (P<0.001) in the levels of 
cholesterol and triglycerides whereas an extremely 
significant increase in HDL cholesterol was observed 
(Table 3). 
 
Effect on Kidney function markers 
Kidney function markers like creatinine, urea and 
albumin were elevated in the alloxan induced diabetic 
rats when compared with the normal rats while total 
protein level is decreased when compared with the 
normal rats. Stevioside reduced the levels of creatinine, 
urea and albumin and increased the levels of total protein 
when compared to toxic control (Table 4). 
 
Histology of Kidney (Figure 1)  
Histology of kidney in normal rats showed the 
normal structure (A). In diabetic rats, mild thickening of 
the basement membrane of the arterioles of glomeruli 
along with severe tissue degranulation were observed. 
No other significant changes were seen (B). These 
changes were improved towards normal on treatment 
with standard (C) and Stevioside (D). 
Figure1. Histopathology of rat kidney tissue in 
Alloxan induced diabetic nephropathy  
 
 
 
 
Effect of Standard and Stevioside (250mg/kg) on rat 
kidney in alloxan induced diabetic 
nephropathy :A:Normal rats, B: Diabetic rats, C: 
Standard Treated, D: Stevioside Treated.  
 
A B 
C D 
Tables and Figures  
 
Table 1: Effect of Stevioside on the serum blood glucose levels  
 
All values are mean ± SEM, n=9,*p<0.05, **p < 0.01when compared to normal control,##p<0.01,###p< 0.001 
compared to toxic control. 
 
Table 2: Effect of Stevioside on antioxidant levels in KTH  
 
All values are mean ± SEM, n=9,*p<0.05, **p < 0.01, ***p < 0.001 when compared to normal control, ##p<0.01,###p< 
0.001 compared to toxic control. 
Groups/ 
Treatment 
                                    Blood glucose level 
Day 7 Day 14 Day 21 Day 28 
Normal control 106.28 ±4.50 105.34±3.80 98.70±5.20 97.35 ± 9.33 
Toxic control 249.53 ±2.47*** 258.54 ±4.25*** 265.46 ±4.27*** 281.33 ± 4.80*** 
Standard 230.24 ±2.38*** 215.23±3.52***## 132.31±2.34**### 122.00 ± 3.05 ### 
Stevioside 235.21 ±2.24*** 230.20 ±2.25***## 184.20 ±2.25***## 133.2 ± 4.34**### 
Groups/ 
Treatment 
SOD 
(unit/mg protein) 
Catalase 
(unit/mg protein) 
Lipid peroxidation 
(unit/mg protein) 
Normal control 80.73±2.65 0.68± 0.01 1.76±0.11 
Toxic control 11.71±1.11*** 0.17±0.01 *** 4.59± 0.12*** 
Standard 59.47±0.67***### 0.55± 0.02**### 2.28±0.11*### 
Stevioside 50.66 ± 0.67***### 0.47± 0.008***### 3.13± 0.04***## 
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Table 3: Effect of Stevioside on Lipoproteins (mg/dL) 
 
All values are mean ± SEM, n=9, *p<0.05 and ***p < 0.001 when compared to normal control,###p< 0.001 
compared to toxic control. 
 
Table 4:  Effect of Stevioside on Kidney function markers 
 
All values are mean ± SEM, n=9,*p< 0.05, **p< 0.01 and***p< 0.001 when compared to normal control ###p<0.001 
compared to toxic control 
Groups/ Treatment Serum HDL-C Serum TC Serum TG 
Normal control 236.59± 3.63 146.60± 6.90 37.83± 3.76 
Toxic control 108.03± 1.63*** 254.46± 8.20*** 96.53± 0.94*** 
Standard 224.40± 5.14 ### 158.13± 3.18### 49.35± 7.25### 
Stevioside 236.80± 7.29 ### 173.03± 3.72### 46.47± 4.44 ### 
Groups/  
Treatment 
Serum Urea 
(mg/dL) 
Serum Creatinine 
(mg/dL) 
Serum Albumin 
(mg/dL) 
Total protein 
(mg/dL) 
Normal control 19.45±0.53 1.23± 0 .06 2.24±0.05 78.11±1.41 
Toxic control 44.72± 2.34*** 4.84±0.11 *** 5.26±0.24*** 50.60±0.97 *** 
 
Standard 27.64±0.53
**###
 1.63± 0.05*### 3.24±0.05**### 70.34± 1.21*### 
Stevioside 31.50±1.56**### 2.23±0.06***### 3.55±0.05***### 63.10±2.00  
Discussion 
Alloxan has been used to induce experimental 
diabetes due to the selective destruction of the insulin-
producing pancreatic beta-islets. Alloxan induces a 
multiphasic blood glucose response when injected into 
an experimental animal, which is accompanied by a 
corresponding decrease in the plasma insulin 
concentration followed by sequential ultra-structural 
beta cell changes ultimately leading to necrotic cell 
death (28). 
Convincing evidence has established the role of 
free radicals and oxidative stress in the pathogenesis 
and development of Diabetic nephropathy (29). 
Antioxidants like superoxide dismutase, catalase and 
the non-enzymatic scavengers of hydroxyl radicals have 
been found to protect against alloxan toxicity. A decline 
in level of catalase and SOD in the kidney tissue 
homogenate is due to the excessive generation of ROS 
or by glycation of the enzyme which have been noted to 
occur in diabetes (30). 
Diabetes produces disturbances of lipid profiles, 
especially an increased susceptibility to lipid 
peroxidation, which is a critical biomarker of free 
radical-mediated oxidative stress. Hypercholesterolemia 
and hypertriglyceridemia were also observed in diabetic 
group which was decreased significantly with 
Stevioside. The observed hypolipidemic effect may be 
due to decreased cholesterol and fatty acid synthesis. 
HDL cholesterol level was significantly increased by 
Stevioside treatment. Any combination with antioxidant 
properties might contribute to the partial or total 
alleviation of oxidative damage (31). 
In the present study a decrease in antioxidant 
activity in diabetic rats is observed, which may 
probably be due to the depletion of antioxidants. 
Stevioside is able to provide nephroprotective activity 
by increasing the reduced levels of SOD, Catalase, HDL 
and total protein while reducing the elevated level of 
glucose, creatinine, albumin, urea, lipid peroxidation 
and lipid profile. The probable mechanism of this action 
may be by reducing the production of ROS, preventing 
lipid peroxidation, modulating anti-oxidant enzyme 
levels (e.g. glutathione peroxidase, glutathione 
reductase, glutathione-S-transferase, superoxide 
dismutase and catalase) and the ability to scavenge 
oxidants. Histopathological studies of kidney tissues 
were undertaken and it was found that Stevioside was 
non-toxic and regenerated the toxic effects produced by 
alloxan. 
 
Conclusion 
From our findings, we infer that Stevioside has 
ability to ameliorate oxidative stress in Alloxan induced 
diabetic nephropathy in rats as evidenced by improved 
glycemic and reduced lipid peroxidation along with 
improved antioxidant enzymatic status. Moreover, it 
reverses histologic changes to almost normal due to 
lipid peroxidation which supports the anti oxidant 
property possessed by Stevioside.  
The reported results were exciting, but the exact 
mechanism for the protective activities of Stevioside in 
diabetic nephropathy is still not clear and further 
investigation is required to understand the clear 
pharmacological profile of the same and to interpret the 
findings in clinical application. 
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